在性结肠炎患者中,口服梅萨拉的不依附率:通过元分析进行系统性审查
Cristiano Pagnini1, Elisabetta Antonelli2, Barbara Scrivo3
1Azienda Ospedaliera S. Giovanni Addolorata, 00184 Roma, Italy.
对于性结肠炎患者来说,不坚持口服梅萨拉是很重要的问题,平均率为32%. 解决这种低估是改善治疗效率和患者在炎症性肠病管理中的结果至关重要的.
科学领域:
- 胃肠病学 胃肠病学
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 性结肠炎 (UC) 涉及慢性结肠炎症,这是炎症性肠病 (IBD) 的一个子集.
- 梅萨拉胺是轻度至中度UC的主要治疗方法,但患者的不坚持是关键的,经常被低估的问题.
- 不坚持可以导致疾病并发症和治疗效率降低.
研究的目的:
- 系统地审查和分析关于UC患者口服梅萨拉的不坚持率的文献.
- 识别影响不遵守的因素,如研究设计和地理位置.
主要方法:
- 在PubMed和Cochrane数据库中进行了全面的文献搜索.
- 选择了报告成人UC患者口服梅沙胺不坚持率的研究.
- 提取和分析了研究类型,地理区域,样本大小和依从性评估方法的数据.
主要成果:
- 34项涉及464篇文章的研究被纳入了元分析.
- 口服梅沙胺的平均不坚持率为32%,具有显著的可变性.
- 观察性研究 (47%) 与临床试验 (20%) 的不遵守率更高,并且在地理上有所不同 (北美:54%,欧洲:23%,亚洲:4%).
结论:
- 在UC患者中,口服梅沙胺的不坚持是普遍存在且经常被忽视的问题.
- 跨研究的不一致报告强调了对标准化依从性评估的需要.
- 个性化的医生方法对于提高治疗有效性和管理UC至关重要.
更多相关视频
07:45Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
Published on: September 1, 2017
06:19Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
